ChristopherYKimMD

Cardiology • Farmington, UT

Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Preventive Cardiology, Vascular Medicine

Utah Cardiology

Join to view full profile

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

Office
444 W Bourne Cir
Ste 200
Farmington, UT 84025
Phone+1 801-776-0174

Fax+1 801-825-3904

Summary

I am a board-certified interventional cardiologist with particular interest in venous and peripheral arterial disease. Our group is able to provide comprehensive treatment of peripheral arterial disease as well as venous disease including DVTs, chronic venous insufficiency, venous stasis and varicose veins.

Education & Training

University of Texas Health Science Center at HoustonFellowship, Interventional Cardiology, 2010 - 2011
University of Texas Health Science Center at HoustonFellowship, Cardiovascular Disease, 2007 - 2010
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2004 - 2007
University of Cincinnati College of MedicineClass of 2004
University of MichiganBA, Sociology, 1994 - 1998

Certifications & Licensure

UT State Medical License 2011 - 2026
TX State Medical License 2008 - 2011
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
Inductee Alpha Omega Alpha Honor Medical Society

Clinical Trials

EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events Start of enrollment: 2010 Apr 01
Completed
Phase 4
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions Start of enrollment: 2010 May 01
Completed
Not Applicable
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) Start of enrollment: 2011 Apr 11
Completed
Phase 3
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) Start of enrollment: 2011 Oct 01
Completed
Phase 3
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease Start of enrollment: 2012 Jun 01
Terminated
Phase 3
Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Start of enrollment: 2013 Feb 08
Completed
Phase 3
ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial Start of enrollment: 2013 Sep 24
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

210 citations
Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II).
Jeffrey W. Chambers, Robert L. Feldman, Stevan I. Himmelstein, Rohit Bhatheja, Augusto E. Villa
JACC. Cardiovascular Interventions. 2014-05-01
52 citations
Orbital Atherectomy for Treating De Novo Severely Calcified Coronary Narrowing (1-Year Results from the Pivotal ORBIT II Trial)
Philippe Généreux, Arthur C. Lee, Christopher Y. Kim, Michael S. Lee, Richard Shlofmitz
The American Journal of Cardiology. 2015-06-15
9 citations
Gender differences in acute and 30-day outcomes after orbital atherectomy treatment of de novo, severely calcified coronary lesions
Christopher Y. Kim, Arthur C. Lee, Troy L. Wiedenbeck, Michael S. Lee, Jeffrey W. Chambers
Catheterization and Cardiovascular Interventions. 2016-03-01

Press Mentions

Non-Healing Leg Ulcers Slowed a Utah Horse-Lover Way DownJuly 7th, 2019

Other Languages

Korean